Literature DB >> 11802946

[Detection of neuroendocrine differentiation in NSCLC and its clinical significance].

N Ouyang1, G Chen, J Ding.   

Abstract

OBJECTIVE: To study differentiation of neuroendocrine (NE) in non-small cell lung carcinoma (NSCLC) and its effect on the responsiveness to chemotherapy.
METHODS: Neuron-specific enolase (NSE), chromogranin A (CgA) and synaptophysin (SYN) were detected in 42 cases of NSCLC by using Western blot and immunohistochemistry. Electron microscopy was also used to observe the ultrastructure of NE granule in above specimens. The relationship between the chemotherapeutic responsiveness and the differentiation of NE in carcinoma tissues was evaluated.
RESULTS: (1) The positive rate of NE detected by Western blot is higher than that detected by immunohistochemistry and electron microscopy. (2) There is no relationship between the expression of NE and the type of lung carcinoma as well as the differentiated degree of carcinoma. (3) The positive rate of three markers detected by immunohistochemistry and Western blot methods in the group of responsive to chemotherapy is higher than that in non-responsive group (P < 0.05).
CONCLUSIONS: There is a high rate of NE differentiation in NSCLC, of which NSE's rate is highest, SYN takes second place, and CgA's rate is lowest. Immunohistochemistry and Western blot method are both very useful for the diagnosis of NE differentiation in NSCLC. The sensitivity of Western blot is higher than immunohistochemistry. The differentiation of NE may be one of the factors effected the chemotherapy in NSCLC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11802946

Source DB:  PubMed          Journal:  Zhonghua Jie He He Hu Xi Za Zhi        ISSN: 1001-0939


  1 in total

1.  [Research on the relationship between non-small cell lung cancer with neuroendocrine differentiation and the biological characteristics and prognosis].

Authors:  Jun Zhang; Kai Zheng; Yan Guo; Peng Zhang; Zhongli Zhan
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2010-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.